ClinicalTrialsFinder

Unfit, New-diagnosis AML Clinical Trials in Suzhou, Jiangsu

1 recruitingSuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University29 enrolled1 locationNCT07451912